Skip Nav Destination
Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles
Issue Archive
December 1 2007
Table of Contents
INSIDE BLOOD
BLOOD WORK
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles
Clinical Trials & Observations
Giovanni Emilia,Mario Luppi,Patrizia Zucchini,Monica Morselli,Leonardo Potenza,Fabio Forghieri,Francesco Volzone,Gordana Jovic,Giovanna Leonardi,Amedea Donelli,Giuseppe Torelli
ERRATUM
GENE THERAPY
Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft
Marina Deschamps,Patricia Mercier-Lethondal,Jean Marie Certoux,Carole Henry,Bruno Lioure,Céline Pagneux,Jean Yves Cahn,Eric Deconinck,Eric Robinet,Pierre Tiberghien,Christophe Ferrand
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Rapidly induced, T-cell–independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells
Shengqiao Li,Yehong Yan,Yuan Lin,Dominique M. Bullens,Omer Rutgeerts,Jozef Goebels,Constant Segers,Louis Boon,Ahmad Kasran,Rita De Vos,Christiane Dewolf-Peeters,Mark Waer,An D. Billiau
CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance
Abderrahim Naji,Solene Le Rond,Antoine Durrbach,Irene Krawice-Radanne,Caroline Creput,Marina Daouya,Julien Caumartin,Joel LeMaoult,Edgardo D. Carosella,Nathalie Rouas-Freiss
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade
Wei Yu Lin,Qian Gong,Dhaya Seshasayee,Zhonghua Lin,Qinglin Ou,Shiming Ye,Eric Suto,Jean Shu,Wyne Pun Lee,Ching-Wei V. Lee,Germaine Fuh,Maya Leabman,Suhasini Iyer,Kathy Howell,Thomas Gelzleichter,Joseph Beyer,Dimitry Danilenko,Sherry Yeh,Laura E. DeForge,Allen Ebens,Jeffrey S. Thompson,Christine Ambrose,Mercedesz Balazs,Melissa A. Starovasnik,Flavius Martin
NEOPLASIA
Establishment of transplantable porcine tumor cell lines derived from MHC- inbred miniature swine
Patricia S. Cho,Diana P. Lo,Krzysztof J. Wikiel,Haley C. Rowland,Rebecca C. Coburn,Isabel M. McMorrow,Jennifer G. Goodrich,J. Scott Arn,Robert A. Billiter,Stuart L. Houser,Akira Shimizu,Yong-Guang Yang,David H. Sachs,Christene A. Huang
Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors
Jorge Cortes,Elias Jabbour,Hagop Kantarjian,C. Cameron Yin,Jianqin Shan,Susan O'Brien,Guillermo Garcia-Manero,Francis Giles,Megan Breeden,Nubia Reeves,William G. Wierda,Dan Jones
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group
Nikola Hagedorn,Cécile Acquaviva,Eva Fronkova,Arend von Stackelberg,Andrea Barth,Udo zur Stadt,André Schrauder,Jan Trka,Nathalie Gaspar,Karl Seeger,Günter Henze,Hélène Cavé,Cornelia Eckert
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis
Giovanni Barosi,Gaetano Bergamaschi,Monia Marchetti,Alessandro M. Vannucchi,Paola Guglielmelli,Elisabetta Antonioli,Margherita Massa,Vittorio Rosti,Rita Campanelli,Laura Villani,Gianluca Viarengo,Elisabetta Gattoni,Giancarla Gerli,Giorgina Specchia,Carmine Tinelli,Alessandro Rambaldi,Tiziano Barbui,for the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Italian Registry of Myelofibrosis
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin
Xinliang Mao,A. Keith Stewart,Rose Hurren,Alessandro Datti,Xuegong Zhu,Yuanxiao Zhu,Changxin Shi,Kyle Lee,Rodger Tiedemann,Yanina Eberhard,Suzanne Trudel,Shengben Liang,Seth J. Corey,Lisa C. Gillis,Dwayne L. Barber,Jeffery L. Wrana,Shereen Ezzat,Aaron D. Schimmer
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
Uwe Rix,Oliver Hantschel,Gerhard Dürnberger,Lily L. Remsing Rix,Melanie Planyavsky,Nora V. Fernbach,Ines Kaupe,Keiryn L. Bennett,Peter Valent,Jacques Colinge,Thomas Köcher,Giulio Superti-Furga
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity
Deborah L. White,Verity A. Saunders,Phuong Dang,Jane Engler,Amity Venables,Stephanie Zrim,Andrew Zannettino,Kevin Lynch,Paul W. Manley,Timothy Hughes
PHAGOCYTES
Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis
Chahrazade Kantari,Magali Pederzoli-Ribeil,Omid Amir-Moazami,Valérie Gausson-Dorey,Ivan Cruz Moura,Marie-Christine Lecomte,Marc Benhamou,Véronique Witko-Sarsat
RED CELLS
STEM CELLS IN HEMATOLOGY
Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling
Linlin Wang,Thomas C. Schulz,Eric S. Sherrer,Derek S. Dauphin,Soojung Shin,Angelique M. Nelson,Carol B. Ware,Mei Zhan,Chao-Zhong Song,Xiaoji Chen,Sandii N. Brimble,Amanda McLean,Maria J. Galeano,Elizabeth W. Uhl,Kevin A. D'Amour,Jonathan D. Chesnut,Mahendra S. Rao,C. Anthony Blau,Allan J. Robins
TRANSFUSION MEDICINE
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
Peter Hillmen,Petra Muus,Ulrich Dührsen,Antonio M. Risitano,Jörg Schubert,Lucio Luzzatto,Hubert Schrezenmeier,Jeffrey Szer,Robert A. Brodsky,Anita Hill,Gerard Socié,Monica Bessler,Scott A. Rollins,Leonard Bell,Russell P. Rother,Neal S. Young
CORRESPONDENCE
-
Cover Image
Cover Image
![issue cover]()
Tissue factor crystal structure with the sulfur atoms of the proposed labile Cys186-Cys209 disulfide bond in yellow. Does tissue factor encryption/decryption involve modification of this bond by protein disulfide isomerase? See article in this issue by Pendurthi et al (page 3900) and the accompanying Inside Blood commentary by Morrissey (page 3822).
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement
